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Abstract
Background: The heart rate variability (HRV)-derived Analgesia
Nociception Index (ANITM) is a continuous noninvasive tool to assess the
nociception/antinociception balance in unconscious patients. It has been
shown to be superior to haemodynamic variables in detecting
insufficient antinociception in children, while little is known about its
predictive value.
Methods: The primary objective of this prospective observational pilot
study in paediatric surgical patients under sevoflurane anaesthesia was
to compare the predictive value of the ANI and heart rate to help decide
to give additional opioids. The paediatric anaesthesiologist in charge was
blinded to ANI values.
Results: In patients with an ANI value <50 (indicating insufficient
antinociception) at the moment of decision, ANI values dropped from
55 (indicating sufficient antinociception) to 35, starting 60 s before
decision. Within 120 s after administration of fentanyl (1 lg/kg), ANI
values returned to 60. This phenomenon was only observed in the
ANI values derived from HRV data averaged over 2 min. Heart rate
remained unchanged. In patients with ANI values ≥50 at the time of
decision, opioid administration had no effect on ANI or heart rate. The
same accounts for morphine for postoperative analgesia and fentanyl in
case of intraoperative movement.
Conclusions: This study provides evidence of a better predictive value
of the ANI in detecting insufficient antinociception in paediatric surgical
patients than heart rate. The same accounts for depicting re-
establishment of sufficient antinociception after opioid drug
administration.
Significance: In paediatric surgical patients anaesthetized with
sevoflurane, the heart rate variability-derived Analgesia Nociception
Index (ANI) appears to be a better predictor of insufficient
antinociception than heart rate. The ANI also appears to depict re-
establishment of sufficient antinociception better than heart rate.
1. Introduction
It has been one of the biggest desires of (paediatric)
anaesthetists for many years to have a valid noninvasive
tool available, which provides them with continuous
information regarding the nociception/antinociception
balance of their unconscious patients. In the absence of
this long-awaited tool, assessment of the nociception/
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antinociception balance in anaesthetized patients is per-
formed using surrogate parameters, such as heart rate
and blood pressure, together with other clinical signs
such as sweating or movement. These parameters are
known to have low sensitivity and specificity in
detecting inadequate antinociception, possibly result-
ing in under- or overdosing of opioid drugs (Daccache
et al., 2017). Probably, the most frequently applied
heuristic approach to help decide whether or not an
anaesthetized patient needs additional opioids is the
clinical impression of the anaesthetist. This assump-
tion appears to be so self-evidently true that there are
no published data available in the scientific literature
supporting it.
During the last two decades, a variety of analgesia
monitoring systems have become commercially avail-
able. To detect analgesia or nociception/antinociception,
these devices use surrogate parameters, such as skin
conductance, plethysmography, pupillometry and heart
rate variability analysis (Gruenewald and Ilies, 2013).
Recent studies performed in anaesthetized children
suggest that the heart rate variability-derived Anal-
gesia Nociception Index (ANITM; Mdoloris Medical
Systems, Loos, France) may provide a more sensitive
assessment of the nociception/antinociception bal-
ance than haemodynamic parameters (Migeon et al.,
2013; Sabourdin et al., 2013). These paediatric stud-
ies are in accordance with the results of studies
investigating the performance of the ANI in anaes-
thetized adult patients (Gruenewald et al., 2013,
2015; Boselli et al., 2015).
While there is a growing body of evidence showing
the ability of the ANI to provide valid information
regarding the nociception/antinociception balance in
anaesthetized patients, little is known about its value
in predicting inadequate antinociception.
The primary objective of this prospective observa-
tional pilot study in paediatric surgical patients
under sevoflurane anaesthesia was to compare the
predictive value of ANI and heart rate to help the
anaesthetist decide to give additional opioid anal-
gesics. Major secondary objectives were the impact
of per-protocol opioid administration for postopera-
tive and caudal analgesia on the course of the ANI.
Changes in ANI values were compared to concomi-
tant changes in heart rate for all analyses.
2. Methods
2.1 Participants and data collection
Paediatric patients, aged between 2 and 12 years,
scheduled for elective surgery under sevoflurane
anaesthesia at Erasmus MC – Sophia Children’s
Hospital, Rotterdam, the Netherlands, were eligible
for inclusion in this prospective observational study.
Technical requirements of the ANI algorithm
resulted in the definition of the following primary
exclusion criteria: cardiac rhythm other than sinus
rhythm, or an internal cardiac pacemaker, high fre-
quency or jet ventilation during surgery.
2.1.1 The Analgesia Nociception Index (ANI)
The Analgesia Nociception Index (ANI) is calculated
by the PhysioDolorisTM monitor (Mdoloris Medical
Systems, Loos, France) using the ECG signal
recorded by and extracted from the standard anaes-
thesia patient monitoring system (Dr€ager Infinity,
Dr€agerwerk AG & Co. KGaA, L€ubeck, Germany)
without the need for additional ECG electrodes.
The basic principle of the ANI is the real-time
analysis of the parasympathetic (pS) activity of the
autonomous nervous system by means of heart rate
variability (HRV) analysis. A fast wavelet transform
rejects any other HRV signal than the high-fre-
quency band (0.15–0.4 Hz), expressing the physio-
logical respiratory sinus arrhythmia. Based on these
filtered data, the ANI, a dimensionless numerical
value, is calculated. The ANI ranges from 0 to 100
and is related to the relative pS activity, with high
index values indicating a high level of pS activity
and vice versa (Daccache et al., 2017). The ANI
serves as a surrogate parameter of the nociception/
antinociception balance in unconscious patients. An
ANI value of 50 has been suggested as a threshold to
distinguish between adequate and inadequate
antinociception in anaesthetized patients (Daccache
et al., 2017). An in-depth description of the ANI
algorithm has been published by Jeanne et al.
(2009).
The PhysioDoloris monitor displays two ANI val-
ues, which differ with regard to the cycle of their
moving average windows: The fast ANIi (i = instant)
is derived from a moving average time of 120 s,
whereas the ANIa (a = average) is derived from a
240 s window (Jeanne et al., 2014).
2.1.2 Intraoperative collection of study data
Analgesia Nociception Index and heart rate data,
recorded during the anaesthetic, were downloaded
from the PhysioDoloris monitor as .txt-files. Data
derived from the Dr€ager Infinity patient monitoring
system were exported as .xls files. Only data
recorded during the surgery were used for subse-
quent analysis.
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During the surgical procedure, the paediatric
anaesthetist in charge was blinded to the screen of
the PhysioDoloris monitor and the conduct of the
anaesthetic was totally unrestricted. Each decision to
give an opioid analgesic, together with the motiva-
tion to do so, was announced to a researcher who
recorded this decision and the subsequent drug
administration.
2.2 Ethical consideration
This prospective observational pilot study was
approved by the Medical Ethics Review Board of
Erasmus University Medical Center, Rotterdam, the
Netherlands (MEC-2016-501, 9 August 2016). The
study was conducted in accordance with the Decla-
ration of the World Medical Association. Written
informed consent was obtained from the parents or
legal guardians of all participating patients.
2.3 Statistical analysis
Analyses were performed using data related to
predefined events. An event was defined as the
intraoperative administration of opioid drugs, either
due to clinical judgement of insufficient antinocicep-
tion or per-protocol administration for postoperative
analgesia.
Repeated measures one-way ANOVA with subse-
quent Holm–Sidak’s multiple comparison test was
performed to investigate the course of ANIi, ANIa
and HR values for the primary objective of the study
during a 120-s period both before the clinical judge-
ment of insufficient antinociception and after subse-
quent opioid drug application. ANOVA was
performed separately for cases when the ANI was
either <50 or ≥50 at the time of decision to adminis-
ter additional opioid analgesia. For the secondary
objectives, ANOVA, using the same set of parame-
ters, was performed to investigate the impact of opi-
oid drug administration due to patient movement
during surgery, per-protocol application of morphine
for postoperative analgesia and following caudal
epidural analgesia.
Unfortunately, we had no scientifically sound
data available on which we could have based a
valid sample size calculation. We assumed that
data from at least 100 patients should provide us
with sufficient information to further develop our
research efforts regarding monitoring of the noci-
ception/antinociception balance in anaesthetized
children. The duration of the project was set to
3 months, which, based on our average annual
number of anaesthetics performed in children
between 2 and 13 years, should be sufficient to
include ≥100 participants.
2.4 Software
Statistical analysis was performed using Prism 7 for
Mac OS X (Version 7.0D, GraphPad Software Inc., La
Jolla, CA, USA).
3. Results
3.1 Participant demographics and general
patient information
A total of 131 patients (female/male: 63/68) could
be recruited for participation during a three-month
inclusion period (03-06/2017). Patient age and
weight were 84.7  33.7 months and 25.9 
11.4 kg, respectively. Information regarding the sur-
gical procedures and anaesthesia techniques is given
in Table 1. According to departmental standards,
patients received intravenous paracetamol 20 mg/kg
and diclofenac 1 mg/kg during the procedure for
postoperative analgesia.
Due to permanent data logging errors, three
patients had to be excluded from data analysis. Data
sets from 35 events (intraoperative opioid drug
administration) had to be excluded from analysis
due to incidental data logging errors. Data sets from
52 events (intraoperative opioid drug administration)
and 10 patients who had a supplemental caudal
block were available for analysis.
3.2 Course of ANI values around opioid
administration
Data from 14 events recorded in patients with ANI
values <50 at the time of decision, indicating
Table 1 Distribution of surgical procedures performed, together with
anaesthesia technique.
Type of surgery
Anaesthesia technique
General
anaesthesia
General anaesthesia
with caudal block
Ear nose & throat surgery 33
Eye surgery 13
General paediatric surgery 26 5
Neurosurgery 3
Oral & maxillofacial surgery 14
Orthopaedic surgery 7 1
Plastic surgery 20
Radiology intervention 1
Urological surgery 1 4
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insufficient antinociception, were available for analy-
sis. ANIi values at the time of decision to give opioid
drugs due to a perceived rise in heart rate were
lower than 60, 90 and 120 s before. Opioid drug
administration (fentanyl, on average 0.8 lg/kg)
resulted in a significant rise in ANIi, starting at 60 s
and reaching predecision values after 120 s. ANIa
and heart rate remained unchanged during the
entire period (see Fig. 1).
Data from 13 events recorded in patients with ANI
values ≥50 at the time of decision, indicating
sufficient antinociception, showed stable values ANIi
and ANIa and heart rate values during the entire
period before and after opioid drug administration
(fentanyl, on average 1.0 lg/kg). For details, see
Fig. 2.
Opioid administration due to patient move-
ment during surgery (nine events) had no effect
on ANIi, ANIa and heart rate. For details, see
Fig. 3.
Per-protocol administration of morphine 0.1 mg/
kg for postoperative analgesia had no effect on ANIi,
ANIa and heart rate, as revealed by analysis of 16
events. For details, see Fig. 4.
3.3 Course of ANI values in patients with
supplemental caudal block
Within 2 min after surgical incision, which was
allowed to be performed no earlier than 10 min after
caudal–epidural injection of ropivacaine 0.2%, 1–
1.2 mL/kg, we observed a decline in average ANIa
values from 82  19 to 68  .21 (p = 0.019), still
indicative of sufficient antinociception. These change
could not be observed in average ANIi or heart rate
values (Fig. 5).
Figure 1 Course of the Analgesia Nociception Index (ANI) and heart rate (HR) values before and after i.v. opioid drug administration in patients
with ANIi values <50 (indicating insufficient antinociception) at the moment of decision. (ANIi: values averaged over 120 s; ANIa: values averaged
over 240 s).
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4. Discussion
The results of this observational pilot study provide
evidence of the predictive value of the ANIi in
detecting insufficient antinociception in paediatric
surgical patients under sevoflurane anaesthesia.
There is also evidence that the ANIi is depictive of
re-establishment of sufficient analgesia after opioid
drug administration.
Although these are certainly a promising findings,
we have to acknowledge the following significant
methodological issue associated with the attempts to
investigate the validity of nociception/antinociception
monitoring systems: The most frequently chosen
approach to investigate the validity of nociception/
antinociception monitors is to compare their values to
heart rate and/or blood pressure, regarded as the
golden standard, although it is nowadays commonly
accepted that heart rate and blood pressure are poor
predictors of insufficient antinociception (Daccache
et al., 2017). Our study was designed under the pre-
requisite of acknowledging the assumption that the
ANI is capable of detecting noxious stimuli with a
higher sensitivity than the clinical standard parame-
ters, heart rate and blood pressure. A growing body of
evidence suggests that this assumption may be true:
Sabourdin et al. (2013) investigated the reaction
of the ANI to a standardized tetanic stimulation in
paediatric patients anaesthetized with desflurane–
remifentanil and found the ANI to be a more sensi-
tive indicator of nociception than heart rate and
blood pressure.
In another paediatric study, performed in children
anaesthetized with sevoflurane, Migeon et al. (2013)
found the ANI to be a useful tool to assess efficacy
of regional anaesthesia, both as a stand-alone tool
and in combination with heart rate changes.
Figure 2 Course of the Analgesia Nociception Index (ANI) and heart rate (HR) values before and after i.v. opioid drug administration in patients
with ANIi values ≥50 (indicating sufficient antinociception) at the moment of decision. (ANIi: values averaged over 120 s; ANIa: values averaged
over 240 s).
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Bobkowski et al. (2017) reported a significant
impact of patient age on HRV in children aged
between 3 and 12 years, except from HRV contribu-
tors derived from high-frequency oscillations. The
ANI algorithm is entirely based on high-frequency
oscillations (Daccache et al., 2017), making it very
unlikely that patient age significantly contributes to
outcome in our study.
Gruenewald et al. (2013) reported that the ANI
was capable of reflecting noxious stimulation in
adult patients anaesthetized with propofol–remifen-
tanil and sevoflurane–remifentanil (Gruenewald
et al., 2015). The authors concluded the ANI may be
an indicator of the nociception/antinociception bal-
ance, without being of predictive value (Gruenewald
et al., 2013). Their study design was to apply stan-
dardized painful tetanic stimulation under increasing
remifentanil effect site concentrations. As opposed to
Gruenewald et al., we found evidence of a predictive
value of the ANIi to detect insufficient antinocicep-
tion. This difference in outcome is most likely due to
the differences in study design. Whereas Gruenewald
et al. applied a controlled 30-s stimulus prior to the
start of the surgical procedure, our study aimed to
investigate the performance of the ANI during the
surgical procedure.
Jeanne et al. (2012) performed a study in adult
patients under propofol–remifentanil anaesthesia and
concluded that it was likely that the ANI is more
sensitive to moderate noxious stimulation than heart
rate and blood pressure.
Our study focused on the variation of the ANI
around an event defined by the attending anaes-
thetist (need for opioid analgesia). The design of our
study allowed the anaesthetist, who was blinded to
ANI values, to be totally unrestricted regarding the
parameters he applied to assess the appropriateness
or inappropriateness of the level of antinociception
Figure 3 Course of the Analgesia Nociception Index (ANI) and heart rate (HR) values before and after i.v. opioid drug administration due to move-
ment during surgery. (ANIi: values averaged over 120 s; ANIa: values averaged over 240 s).
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during the surgical procedure. Perceived rise in heart
rate was the most commonly reported reason to give
additional opioid drug. Interestingly, these perceived
rises in heart rate were very small, most frequently
several beats/min only. In patients presenting with
ANIi values <50 at the time of decision to give
additional opioids, this ANIi value was significantly
lower than 60, 90 and 120 s before. Furthermore,
within 120 s after opioid drug administration, it
returned to the same level of around 60 units like
120 s before the diagnosis of insufficient antinocicep-
tion. As opposed to the ANIi, the ANIa remained
unchanged. In patients presenting with ANIi values
≥50 at the time of decision to give additional opioids,
none of the investigated parameters (ANIi, ANIa and
heart rate) showed any changes before and after opi-
oid drug administration. The same accounts for the
course of ANIi, ANIa and heart rate after per-protocol
administration of morphine for postoperative analge-
sia, where the mean baseline ANIi was about 70
units, indicating sufficient antinociception.
Patient movement during surgery can be regarded as
a sign of insufficient antinociception. In our series of
nine events when opioid drugs were given due to
patient movement, there were no significant changes
in either ANIi, ANIa or heart rate. Movement could as
well have been a result of too light anaesthesia. Unfor-
tunately, depth of hypnosis monitoring was not applied
in any patient, so we can only speculate on this.
The results of our study allow us to suggest the
following theory:
In paediatric surgical patients under sevoflurane
anaesthesia, ANIi values of 35, especially after a
decline from 55 within 2 min, most likely reflect
insufficient antinociception, even without an evi-
dent raise in heart rate. A single dose of 1 lg/kg
fentanyl resulted in a return to ANIi values of
58, suggesting sufficient antinociception, within
2 min. The ANIa, averaged over 4 min did not
show this phenomenon. It seems as if a 4 min
averaging period is too long to reflect the typically
instantaneous changes in the nociception/antinoci-
ception balance during a surgical procedure.
4.1 Limitations
When designing our study, we originally also wanted
to investigate the impact of per-protocol administra-
tion of opioid drugs immediately before the surgical
incision on ANI and heart rate. Unfortunately, many
disruptive nonpainful interventions (patient position-
ing, application of neutral electrodes for electrocoagu-
lation, etc.) routinely take place during this particular
period, resulting in poor ECG signal quality. We there-
fore decided to restrict our data analysis period to the
duration of the surgical procedure.
We decided to restrict our analysis to the course of
heart rate, leaving blood pressure unnoticed, which
could be regarded as a shortcoming of our study
Figure 4 Course of the Analgesia Nociception Index (ANI) and heart
rate (HR) values following per-protocol i.v. morphine administration for
postoperative analgesia. (ANIi: values averaged over 120 s; ANIa: val-
ues averaged over 240 s).
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design. This decision was due to the fact that, in our
daily practice of paediatric anaesthesia, noninvasive
blood pressure is measured at 5-min intervals. Com-
pared to the ANI and heart rate, which were avail-
able at 1-s intervals, this would have been a far too
long interval to result in any meaningful conclusion.
4.2 Future directions
Future studies in paediatric surgical patients should
focus on defining optimum doses of opioid drugs to
re-establish ANI values indicating sufficient intraop-
erative antinociception after a decline in ANIi values
below the threshold of 50. Furthermore, the ANI
may help to prevent excessive opioid drug adminis-
tration. Too much opioid drug can result in acute l-
receptor desensitization, contributing to opioid drug
failure to provide postoperative analgesia. Of special
interest for paediatric care is the impact of opioid
drugs on postanaesthesia respiratory patterns. ANI-
derived opioid intervention guidelines would enable
us to conduct outcome studies in paediatric surgical
patients, focusing on postoperative pain and opioid
drug side effects.
An integrated approach using ANI monitoring and
processed EEG would cover both nociception/
antinociception and depth of hypnosis. The ANI may
bring us closer to monitoring depth of anaesthesia as
a whole. Well-designed future clinical studies will
have to show if it is possible to develop such an inte-
grated approach to depth of anaesthesia monitoring
(in children).
Figure 5 Course of the Analgesia Nociception Index (ANI) and heart rate (HR) values before and after caudal block (left) and surgical incision
(right). (ANIi: values averaged over 120 s; ANIa: values averaged over 240 s).
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5. Conclusions
In paediatric surgical patients anaesthetized with
sevoflurane, a decline of the ANIi from values around
60 to values around 35 is indicative of insufficient
antinociception. After opioid drug administration, the
ANIi returns to values around 60, suggesting sufficient
antinociception. This phenomenon does not necessarily
need to be accompanied by haemodynamic changes,
suggesting the superiority of the ANIi over heart rate as
a predictive tool to detect insufficient antinociception
and as an indicator of re-establishment of sufficient
antinociception after opioid drug administration.
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